Patient Guide: A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 99 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06564844
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 99 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tucson, Arizona
  • Duarte, California
  • Glendale, California
  • • And 96 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily